Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
CT-388 (also known as RO7795068) is a signal-biased dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist developed by Roche/Genentech
Compression garments
Curcumin Curcumin, the active compound in turmeric, has shown promise in animal studies for increasing GLP-1 and improving blood sugar control
Results from the phase 1 human study show weight loss of 14% in 30 days with decreases in glucose, glucagon and C-reactive protein and an acceptable safety profile.48 It allows monthly subcutaneous administration
It can help with mild to moderate laxity by supporting collagen rebuilding and tightening, and it can be used on both face and select body areas
